Ito, F., Iwata, W., Adachi, Y., Sesaki, H., & Iijima, M. GRHL2-HER3 and E-cadherin mediate EGFR-bypass drug resistance in lung cancer cells. Frontiers Media S.A.
Chicago Style (17th ed.) CitationIto, Fumiya, Wakiko Iwata, Yoshihiro Adachi, Hiromi Sesaki, and Miho Iijima. GRHL2-HER3 and E-cadherin Mediate EGFR-bypass Drug Resistance in Lung Cancer Cells. Frontiers Media S.A.
MLA (9th ed.) CitationIto, Fumiya, et al. GRHL2-HER3 and E-cadherin Mediate EGFR-bypass Drug Resistance in Lung Cancer Cells. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.